Choose your category
- All
- CONTENT
- CORPORATE
- CSR
- EVENT
- PRODUCT
- SCIENCE
- TRENDS
On the occasion of the publication of the Lactalis Group’s 2025 CSR Report, Lactalis Ingredients Pharma reaffirms its commitment to a sustainable future. Driven by the Group’s new CSR programme, “Our Sustainable Way to Go”, Lactalis is accelerating its local initiatives to combine expertise, quality, and resource preservation.
Maeva Croué was invited to appear on the set of Talk de la Rédaction by L’Usine Nouvelle for an interview focusing on the pharmaceutical industry. The discussion explored a key question shaping the sector today: “From sovereignty to performance: what strategic transformations are needed for the pharmaceutical industry?”
A significant proportion of new drug candidates present limited aqueous solubility. This is a well-documented formulation challenge, particularly for oral solid dosage forms, where the performance of the final product depends not only on the API itself, but also on the way the formulation supports dissolution under physiological conditions.
